213 related articles for article (PubMed ID: 20173392)
1. TNF and bone.
David JP; Schett G
Curr Dir Autoimmun; 2010; 11():135-44. PubMed ID: 20173392
[TBL] [Abstract][Full Text] [Related]
2. Impaired fracture healing in the absence of TNF-alpha signaling: the role of TNF-alpha in endochondral cartilage resorption.
Gerstenfeld LC; Cho TJ; Kon T; Aizawa T; Tsay A; Fitch J; Barnes GL; Graves DT; Einhorn TA
J Bone Miner Res; 2003 Sep; 18(9):1584-92. PubMed ID: 12968667
[TBL] [Abstract][Full Text] [Related]
3. [The cytokine system of bone tissue].
Stilgren LS; Abrahamsen B; Abdallah BM; Jørgensen NR
Ugeskr Laeger; 2005 Feb; 167(8):874-8. PubMed ID: 15789838
[No Abstract] [Full Text] [Related]
4. Bone remodeling.
Hadjidakis DJ; Androulakis II
Ann N Y Acad Sci; 2006 Dec; 1092():385-96. PubMed ID: 17308163
[TBL] [Abstract][Full Text] [Related]
5. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems.
Takayanagi H
Nat Rev Immunol; 2007 Apr; 7(4):292-304. PubMed ID: 17380158
[TBL] [Abstract][Full Text] [Related]
6. Regulatory roles and molecular signaling of TNF family members in osteoclasts.
Feng X
Gene; 2005 Apr; 350(1):1-13. PubMed ID: 15777737
[TBL] [Abstract][Full Text] [Related]
7. [Recent advances in basic research of bone metabolism].
Inoue D; Matsumoto T
Nihon Rinsho; 2002 Mar; 60 Suppl 3():25-33. PubMed ID: 11979916
[No Abstract] [Full Text] [Related]
8. [Bone following the menopause].
Peretz A
Rev Med Brux; 1995; 16(4):280-4. PubMed ID: 7481243
[TBL] [Abstract][Full Text] [Related]
9. T cells and post menopausal osteoporosis in murine models.
Pacifici R
Arthritis Res Ther; 2007; 9(2):102. PubMed ID: 17349065
[TBL] [Abstract][Full Text] [Related]
10. A new member of tumor necrosis factor ligand family, ODF/OPGL/TRANCE/RANKL, regulates osteoclast differentiation and function.
Takahashi N; Udagawa N; Suda T
Biochem Biophys Res Commun; 1999 Mar; 256(3):449-55. PubMed ID: 10080918
[TBL] [Abstract][Full Text] [Related]
11. Effects of TNF and lymphotoxin on bone cells.
Mundy GR; Roodman GD; Bonewald LF; Yoneda T; Sabatini M
Immunol Ser; 1992; 56():483-98. PubMed ID: 1550873
[No Abstract] [Full Text] [Related]
12. Tumor necrosis factor family receptors regulating bone turnover: new observations in osteoblastic and osteoclastic cell lines.
Robinson LJ; Borysenko CW; Blair HC
Ann N Y Acad Sci; 2007 Nov; 1116():432-43. PubMed ID: 17646260
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor-alpha: alternative role as an inhibitor of osteoclast formation in vitro.
Balga R; Wetterwald A; Portenier J; Dolder S; Mueller C; Hofstetter W
Bone; 2006 Aug; 39(2):325-35. PubMed ID: 16580896
[TBL] [Abstract][Full Text] [Related]
14. Taking a toll on the bones: regulation of bone metabolism by innate immune regulators.
Bar-Shavit Z
Autoimmunity; 2008 Apr; 41(3):195-203. PubMed ID: 18365832
[TBL] [Abstract][Full Text] [Related]
15. [Adhesion molecules in the context with bone remodeling and osteoporosis].
Tanaka Y
Nihon Rinsho; 2004 Feb; 62 Suppl 2():125-30. PubMed ID: 15035110
[No Abstract] [Full Text] [Related]
16. Phenomenological model of bone remodeling cycle containing osteocyte regulation loop.
Moroz A; Crane MC; Smith G; Wimpenny DI
Biosystems; 2006 Jun; 84(3):183-90. PubMed ID: 16387419
[TBL] [Abstract][Full Text] [Related]
17. The cell biology of bone metabolism.
Datta HK; Ng WF; Walker JA; Tuck SP; Varanasi SS
J Clin Pathol; 2008 May; 61(5):577-87. PubMed ID: 18441154
[TBL] [Abstract][Full Text] [Related]
18. Contribution of genetically modified mouse models to the elucidation of bone physiology.
Thomas T; Lafage-Proust MH
Rev Rhum Engl Ed; 1999 Dec; 66(12):728-35. PubMed ID: 10649609
[TBL] [Abstract][Full Text] [Related]
19. Cellular and molecular effects of growth hormone and estrogen on human bone cells.
Kassem M
APMIS Suppl; 1997; 71():1-30. PubMed ID: 9357492
[TBL] [Abstract][Full Text] [Related]
20. [RANKL as a target molecule for treatment of joint destruction].
Tanaka S
Clin Calcium; 2007 Apr; 17(4):586-92. PubMed ID: 17404489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]